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Introduction
Daunorubicin
The Daun02–daunorubicin method is based on the anthracycline 
family of compounds (daunorubicin, doxorubicin and adriamycin, 
among others) that has long been used in anti-cancer treatment, 
especially of tumours in breast, bile ducts, oesophagus, liver and 
leukaemia. These compounds are known to have a large range of 
different cellular effects (ranging from inhibition of DNA synthesis 
to generation of free radicals), although it is not clear which of these 
lead to their effectiveness in cancer treatment (Gewirtz, 1999). In 
addition to effectiveness as a cancer therapy, it was discovered that 
daunorubicin can have devastating consequences for nervous sys-
tem function, resulting from axonal and cerebral atrophy (Mortensen 
et al., 1992). The impact of these compounds on neuronal function 
is of clinical interest because of potential deleterious neurological 
side-effects of cancer treatment, but is also of scientific interest 
because of the potential use of daunorubicin to disrupt neuronal 
activity to examine cellular and circuit mechanisms of behaviour.
Targeting daunorubicin
To target anti-tumor anthracycline therapy to specific cells, the 
Daun02–daunorubicin method was developed (Farquhar et al., 
2002). This method utilised the ability of β-galactosidase to catalyse 
conversion of the inactive prodrug Daun02 to active daunorubicin, 
allowing targeting of just those cells that produce β-galactosidase. 
Retroviral transduction of murine pancreatic tumour cell lines or 
human breast and prostate cell lines with LacZ resulted in produc-
tion of β-galactosidase and conversion of Daun02 to daunorubicin, 
resulting in cell-targeted toxicity. This use of the conversion of the 
inactive Daun02 to active daunorubicin by β-galactosidase opened 
up the possibility of targeting daunorubicin not only to cancer cells 
but also to a range of other biological systems.
Behavioural utility of disrupting 
neuronal function by daunorubicin
Neuronal circuits that mediate  
addiction-related behaviours
The Daun02–daunorubicin method was developed by Bruce 
Hope and colleagues (Koya et al., 2009) who made a key meth-
odological advance by utilising the Fos-LacZ transgenic rat in 
which activation of the Fos promotor induces transcription of 
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LacZ, in turn producing β-galactosidase enzyme in Fos-
expressing neurones. Fos is an immediate early gene which is 
upregulated by neuronal activity (Herrera and Robertson, 1996; 
Tischmeyer and Grimm, 1999) and can therefore be used to pro-
duce β-galactosidase in only those cells that have been strongly 
active in a particular task; those cells can then in turn be selec-
tively manipulated using Daun02. The authors developed this 
technique in order to manipulate neuronal ensembles or a minor-
ity of sparsely distributed sets of neurones activated during 
learned behaviours and/or by specific stimuli (Cruz et al., 2013).
Using this approach, Koya et al. (2009) investigated the 
requirement of nucleus accumbens neuronal ensembles in the 
context-specific sensitisation of cocaine-induced hyperlocomo-
tor activity. This behaviour is dependent on specific learned 
associations between cocaine effects and the cocaine adminis-
tration environment. They first demonstrated that approxi-
mately 2–3% of nucleus accumbens neurones expressed Fos 
during the expression of context-specific sensitisation. 
Subsequently, they demonstrated that intra-accumbens injec-
tions of Daun02 in Fos-LacZ rats applied during the expression 
of this behaviour disrupted its subsequent expression 2–3 days 
later. These findings established a critical role for accumbens 
neuronal ensembles in mediating the aforementioned drug-con-
text associations. Since then, several researchers have used a 
similar Daun02-based approach to identify neuronal ensembles 
in motivationally relevant brain areas (e.g. prefrontal cortex and 
amygdala) that encode learned associations about the behav-
ioural effects of other drugs of abuse such as alcohol (De 
Guglielmo et al., 2016; Pfarr et al., 2015), nicotine (Funk et al., 
2016), heroin (Bossert et al., 2011; Fanous et al., 2013), meth-
amphetamine (Caprioli et al., 2017), cocaine (Cruz et al., 2014) 
or food reward (Suto et al., 2016; Warren et al., 2016) and the 
environmental cues associated with their availability. 
Collectively, these studies demonstrate the utility of the Daun02 
method to establish causal relationships between activated Fos-
expressing neurones and learned behaviours.
Neural circuits of motor control
One of the major side-effects of dopamine replacement 
therapy in Parkinson’s disease is L-DOPA-induced (L-3,4-
dihydroxyphenylalanine) dyskinesia (LID). This dyskinesia is 
associated with increased Fos expression in human striatum 
(Tekumalla et al., 2001) and in animal models of LID (Andersson 
et al., 1999) and may rely on hyperactivity (Hutchinson et al., 
1997) of striatal medium spiny neurones (MSNs). To examine 
whether LID relies on activation within MSNs, Daun02 was used 
as a means to silence activity within these cells (Engeln et al., 
2016). In this case, FosB-LacZ lentivirus was injected into rat 
striatum to produce β-galactosidase. Subsequent infusion of 
Daun02 resulted in a significant reduction in abnormal involun-
tary movements that normally occur during LID. Furthermore, 
Daun02 was also found to be effective in countering LID in 
MPTP-lesioned L-DOPA-treated macaques (Engeln et al., 2016).
Neural circuits of spatial and temporal 
learning
The Daun02 method has also recently been used to enable selec-
tive deactivation of specific connections between brain regions to 
address the role of these connections in learning and memory 
(Barker et al., 2017). This was achieved using an equine 
infectious anemia virus-based VSV-G/rabies-G fusion envelope 
protein lentiviral vector expressing LacZ injected into the medial 
prefrontal cortex (mPFC) to enable retrograde transduction of 
cells projecting directly to mPFC. Injection of Daun02 into those 
areas, such as hippocampus, would be converted to daunorubicin 
by β-galactosidase only in those (hippocampal) neurones which 
project to mPFC. Using this approach, it was demonstrated 
(Barker et al., 2017) that two distinct pathways from CA1 to 
mPFC carry different mnemonic information; thus, silencing of 
the projection from dorsal hippocampus to mPFC selectively dis-
rupted judgements of temporal order learning while silencing of 
projections from intermediate hippocampus-mPFC disrupted 
spatial learning.
Therefore, the use of targeted neuronal manipulation 
achieved by expression of B-gal using either Fos activation or 
viral transduction of specific synaptic pathways to allow con-
version of Daun02 to daunorubicin has proved to be an 
extremely useful method for investigations of neurones 
involved in behaviour.
Mechanisms of neuronal deactivation 
by Daun02–daunorubicin
While it has been demonstrated that the Daun02 method is a 
highly selective tool for targeting specific neuronal ensembles, 
the utility of the system may be limited by its reversibility. We 
shall now discuss that some studies find the effects of Daun02 are 
reversible and may result from decreases in neuronal excitability 
(Barker et al., 2017; Engeln et al., 2016) while others find that 
Daun02 induces apoptotic cell death in LacZ expressing cells 
(Pfarr et al., 2015). The latter finding will limit the number of 
behavioural trials in which Daun02 may be a useful manipulation 
and in some cases may limit experimental cohorts to a ‘one-shot’ 
experiment. Alternatively, it is possible that in the future, non-
reversible apoptotic cell death could be used advantageously in 
humans to block deleterious memories.
Cell death has been considered as one of the primary actions 
of daunorubicin in its function as a cancer treatment. However, 
the mechanism by which cell death occurs in cancer therapy is 
still a matter of some debate (Gewirtz, 1999). In this review, we 
will focus on what is known about the neuronal toxicity of dau-
norubicin action.
Apoptotic neuronal death
Inadvertent intrathecal administration of daunorubicin into a 
human patient resulted in cerebral and axonal atrophy, suggesting 
progressive and prolonged neuronal destruction (Mortensen 
et al., 1992). These effects may at least in part be due to retro-
grade transport as shown by doxorubicin injections in striatum 
leading to cell death in substantia nigra (Van der et al., 1985). In 
support of increased cell death, it was shown that daunorubicin 
resulted in reduced cell viability, as measured by in vitro cell tox-
icity assays (Farquhar et al., 2002). Primary cerebral cultures 
treated with doxorubicin underwent apoptosis that was depend-
ent on metalloproteinase inhibition (Wetzel et al., 2003). IP 
administration of adriamycin to mice resulted in increases in pro-
tein oxidation and lipid peroxidation, suggestive of oxidative 
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stress in the brain (Joshi et al., 2005). In primary neuronal cul-
tures, daunorubicin was demonstrated to induce dose- and time-
dependent cell toxicity as assessed by measures including lactate 
dehydrogenase release, MTT assay, Hoechst’s staining to iden-
tify condensed chromatin, and caspase-3 activity. Interestingly, 
these effects were attenuated by memantine but not by other 
NMDA receptor antagonists (Jantas and Lason, 2009).
However, the above data do not provide evidence as to the 
mechanisms by which Daun02 may alter neuronal function in 
those studies of circuit function described above. Evidence for 
daunorubicin-induced apoptosis in behavioural studies was pro-
vided by injection of Daun02 into mPFC of pCAG-LacZ rats 
which constitutively express LacZ (see Figure 1(A)). This 
resulted in large levels of neurodegeneration, as assessed by 
fluorojade-B staining, which was prevented by co-infusion of the 
caspase inhibitor Z-VAD-FMK (Pfarr et al., 2015). Therefore, 
there is a good deal of evidence from cell lines, neuronal cultures, 
in vivo animal and human data that the anthracillin family of 
compounds can result in neuronal cell death.
Effects on neuronal activity
Early evidence from Santone et al. (1986) in a murine neuroblas-
toma cell line suggested that the daunorubicin family of com-
pounds can have subtle effects on neuronal activity. Differentiation 
of the NIE-115 neuroblastoma cell line results in these develop-
ing sodium- and calcium-dependent action potentials. In the pres-
ence of tetrodotoxin, to block Na channels, it was shown that 
either doxorubicin or daunomycin dose-dependently reduced 
action potential firing (Santone et al., 1986). Doxorubicin was 
shown in both aplysia sensory neurones and rat cortical cultures 
to produce an increase in ERK, p38 MAPK and CREB activation 
without any apparent changes in toxicity (assessed by cell shrink-
age, membrane rupture and neurite degeneration). Interestingly, 
Figure 1. Contrasting effects of Daun02 on cellular condition. (A) cFos-LacZ transgenic rats were implanted with cannulae in infralimbic (IL) cortex 
after being trained to self-administer alcohol. Following cue-induced reinstatement, vehicle or Daun02 was infused into IL. (Ai) 3 days later, rats 
underwent a second reinstatement session and were sacrificed to undergo X-gal staining. (Aii) Daun02-treated animals show significantly lower 
levels of LacZ positive neurones compared to vehicle-treated animals; this is thought to be a result of cell loss caused by apoptosis. (B) Rats were 
given injections of a rabies-envelope pseudotyped virus encoding LacZ into prelimbic cortex to transduce retrogradely projecting neurones. Cannulae 
were implanted in hippocampal CA1 region and animals were infused with vehicle in one hemisphere and Daun02 in the opposite hemisphere 3 days 
before taking acute hippocampal slices: CA1 pyramidal cells from the Daun02 hemispheres fired significantly fewer action potentials in response to 
depolarising current than their vehicle counterparts (Bi), an effect thought to be due to an increase in the action potential threshold of those cells 
(Bii) and an increase in the magnitude of the afterhyperpolarising potential (Biii). Panel A adapted with permission from Pfarr et al. (2015) and 
panel B from Barker et al. (2017).
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doxorubicin was able to prevent long-term facilitation induced 
by 5-HT in aplysia neurones without having any effect on basal 
synaptic transmission or membrane potential by itself, suggest-
ing that while there were no toxic effects, doxorubicin can impact 
synaptic mechanisms (Liu et al., 2014).
To determine the actions of daunorubicin on striatal MSNs, 
Engeln et al. (2016) showed in rat MSN primary cultures express-
ing LacZ that there was strong attenuation of action potential fir-
ing in response to depolarising steps following perfusion of 
Daun02. Importantly, the attenuation of excitability was reversi-
ble upon Daun02 washout, suggesting that any effects of daunoru-
bicin are most likely due to reversible effects on the membrane or 
on specific ion channels. In addition, they were also able to dem-
onstrate in brain slices that daunorubicin applied into the extracel-
lular perfusate resulted in a similar attenuation of MSN excitability. 
Most recently, Barker et al. (2017) investigated effects of dauno-
rubicin on neuronal function in rat hippocampal CA1 neurones. 
This was achieved by bilateral expression of LacZ in hippocampal 
CA1 region. Subsequently, Daun02 was infused into CA1 in one 
hemisphere and saline into the other hemisphere. Horizontal hip-
pocampal slices were taken 3 days later and CA1 pyramidal neu-
rone membrane properties assessed. These data showed that in the 
Daun02 hemisphere compared to control hemisphere, there was a 
decrease in action potential number, which can be explained by an 
increase in action potential threshold and an increase in the size of 
the afterhyperpolarisation; input resistance was not affected by 
Daun02 (see Figure 1(B)).
The studies of Engeln et al. (2016) and Barker et al. (2017) 
show similar results in that the number of action potentials was 
reduced by Daun02–daunorubicin treatment, but the underlying 
mechanism of this is not clear. The increased action potential 
threshold observed by Barker et al. (2017) may be explained by 
inhibition of voltage-gated sodium or calcium channels as 
observed previously (Santone et al., 1986). Additionally, the 
increased afterhyperpolarisation amplitude may be mediated by a 
potentiation of M- and/or h-currents (Gu et al., 2005). It is not 
clear whether the reduced firing observed by Barker et al. (2017) 
and Engeln et al. (2016) are mediated by the same mechanisms. 
The methodology and the time course of treatment differ between 
the two studies: Engeln et al. (2016) observe reduction in firing 
following acute daunorubicin application to a slice or after incu-
bating LacZ-expression neuronal cultures in Daun02 for 2 h. In 
contrast, Barker et al. (2017) infused Daun02 into the hippocam-
pus 3 days before assessing neuronal properties in vitro. As an 
infusate would not be expected to be active beyond a few hours 
(Day et al., 2003), this suggests that the conversion of Daun02 to 
daunorubicin in vivo has a lasting, possibly transcriptional, effect 
on those cells which express β-galactosidase. Together, the 
results of these studies imply that use of the terms ‘silencing’ and 
‘inactivating’ neural ensembles may be inappropriate as the 
effect of Daun02 is merely a reduction in activity where neurones 
can still fire action potentials but with reduced number or 
frequency.
Cell death versus disruption of 
activity
There is strong evidence for the Daun02–daunorubicin method 
affecting neuronal function by either reducing cell activity or by 
inducing cell death. It is also possible that both effects of reduced 
excitability and cell death are occurring in the experiments of 
Barker et al. (2017) and Engeln et al. (2016), and that the electro-
physiological recordings are necessarily selective for the former 
neurones. However, in the case of the behavioural experiments 
carried out by Barker et al. (2017), a single cohort of rats was 
used to perform the Daun02 experiments and these animals 
received multiple Daun02 infusions and yet were continually 
able to perform hippocampal-mPFC-dependent tasks at a high 
level when subsequently pseudo-randomly assigned to the vehi-
cle condition. Given the strong expression of LacZ expression 
observed in the hippocampus in those animals, it appears unlikely 
that widespread cell death was occurring following Daun02 
administration.
An alternative scenario to explain the differences observed in 
cell death and effects on neuronal activity may lie in the methods 
of expressing the LacZ gene: both studies which show non-neu-
rotoxic, reversible effects of Daun02 (Barker et al., 2017; Engeln 
et al., 2016) use a viral strategy to transduce neurones with the 
LacZ gene, whereas Daun02 infusion in cFos-LacZ or pCAG-
LacZ transgenic rats seems to result in cell death (Pfarr et al., 
2015). If the expression method dictates the levels of 
β-galactosidase in labelled cells, this may dictate the rate of con-
version of Daun02, potentially resulting in different maximal 
concentrations of daunorubicin. It remains to be seen under these 
in vivo conditions whether high concentrations are cytotoxic 
while lower concentrations merely affect cell excitability.
Conclusion
The use of Daun02–daunorubicin to probe causal relationships 
between neuronal activity or circuit function and behaviour has 
proved to be highly effective. However, under different condi-
tions, daunorubicin may activate different mechanisms to reduce 
excitability or induce apoptosis. Therefore, different strategies 
may be appropriate for different experimental scenarios; thus, if 
the effects of deactivation in a range of paradigms are required, 
then a reversible effect, such as that produced by viral expression 
of the LacZ gene, would be the method of choice.
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